GlassScriptPhysician profile
Naresh Kumar Nayak
NPI 1356309108
$2,102.59
in general payments reported to CMS, 2019-2025
26 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $187 · 2021: $560 · 2022: $238 · 2023: $286 · 2024: $152 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663 · Consulting Fee: $100 · Education: $55.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.54 |
| Consulting Fee | $100.00 |
| Education | $55.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $347.68 | 2019-2025 | Euflexxa |
| Stryker Corporation | $246.64 | 2022-2025 | Pangea, T2 Alpha, Hoffmann |
| Horizon Therapeutics Plc | $210.45 | 2019-2021 | |
| Abbvie INC. | $192.68 | 2021-2023 | |
| Vericel Corporation | $160.24 | 2019-2022 | |
| Medtronic, INC. | $114.70 | 2021-2023 | Indigo, Skeeter |
| Depuy Synthes Sales INC. | $113.75 | 2021 | |
| Allergan, INC. | $113.20 | 2019-2020 | |
| Smith+Nephew, INC. | $102.02 | 2019-2025 | Pico 14, Stravix Pl, Pico 7 |
| Ultragenyx Pharmaceutical INC. | $65.70 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $64.66 | 2020-2022 | |
| Amgen INC. | $53.74 | 2020-2025 | Evenity, Prolia |
| Vertex Pharmaceuticals Incorporated | $41.52 | 2024-2025 | |
| Acera Surgical, INC. | $36.78 | 2024-2025 | Restrata Wound Matrix |
| Radius Health, INC. | $33.41 | 2023-2025 | Tymlos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $31.04 | 2020 | |
| Bioventus LLC | $23.17 | 2024 | Exogen Ultrasound Bone Healing System |
| Davol INC. | $23.12 | 2019-2021 | |
| Heron Therapeutics, INC. | $22.86 | 2021-2022 | |
| Almatica Pharma LLC | $22.36 | 2025 | Teriparatide |
| Sonex Health, INC. | $17.15 | 2020 | |
| Orthogenrx INC. | $14.68 | 2019 | |
| Medtronic USA, INC. | $14.63 | 2019 | |
| Fidia Pharma USA INC. | $14.34 | 2019 | |
| Checkpoint Surgical, INC | $11.93 | 2023 | Checkpoint Stimulators |
| Orthofix Medical, INC. | $10.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Nayak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.